Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation
- PMID: 16960167
- DOI: 10.1093/ajcn/84.3.540
Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation
Erratum in
- Am J Clin Nutr. 2007 Jun;85(6):1668
Abstract
Background: Effects of fish oil supplements on metabolic variables are insufficiently clarified in type 2 diabetes.
Objective: We aimed to investigate short-term (1 wk) and longer-term (9 wk) effects of n-3 fatty acids.
Design: Twenty-six subjects with type 2 diabetes without hypertriacylglycerolemia participated in a double-blind controlled study. Median intake in the intervention group was 17.6 mL fish oil/d (1.8 g 20:5n-3, 3.0 g 22:6n-3, and 5.9 g total n-3 fatty acids). The control group received 17.8 mL corn oil/d (8.5 g 18:2n-6).
Results: Plasma phospholipid 20:5n-3 and 22:6n-3 increased, whereas 18:2n-6 decreased, in the fish oil group compared with the corn oil group after 1 wk. The two n-3 fatty acids also increased in adipose tissue biopsy samples taken after 9 wk in the fish oil group. Glucose concentrations (home-monitored) were approximately 1 mmol/L higher in the fish oil group than in the corn oil group at the end of the intervention (P = 0.035). Glucose utilization measured by using an isoglycemic clamp was lowered in the fish oil group compared with that in the corn oil group at the end of the intervention (P = 0.049), whereas glucagon-stimulated C-peptide tended to increase (P = 0.078). The fish oil group utilized less fat for oxidation after 1 wk, with a change to more fat and less carbohydrate oxidation after 9 wk (P = 0.040), than did the corn oil group.
Conclusion: A high intake of fish oil moderately increases blood glucose and decreases insulin sensitivity in persons with type 2 diabetes without hypertriacylglycerolemia and alters carbohydrate and fat utilization in a time-dependent manner.
Similar articles
-
Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.Eur J Clin Nutr. 2008 Mar;62(3):419-29. doi: 10.1038/sj.ejcn.1602703. Epub 2007 Feb 28. Eur J Clin Nutr. 2008. PMID: 17327864 Clinical Trial.
-
Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study.Diabetes Care. 1998 May;21(5):717-24. doi: 10.2337/diacare.21.5.717. Diabetes Care. 1998. PMID: 9589230 Clinical Trial.
-
Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?Nutr Metab Cardiovasc Dis. 2007 Oct;17(8):572-80. doi: 10.1016/j.numecd.2006.06.006. Epub 2006 Nov 28. Nutr Metab Cardiovasc Dis. 2007. PMID: 17127043 Clinical Trial.
-
N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients.Ann N Y Acad Sci. 1993 Jun 14;683:16-34. doi: 10.1111/j.1749-6632.1993.tb35689.x. Ann N Y Acad Sci. 1993. PMID: 8352438 Review.
-
N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?Reprod Nutr Dev. 2004 May-Jun;44(3):289-99. doi: 10.1051/rnd:2004033. Reprod Nutr Dev. 2004. PMID: 15460168 Review.
Cited by
-
Effects of Dietary n-3 Fatty Acids on Hepatic and Peripheral Insulin Sensitivity in Insulin-Resistant Humans.Diabetes Care. 2015 Jul;38(7):1228-37. doi: 10.2337/dc14-3101. Epub 2015 Apr 7. Diabetes Care. 2015. PMID: 25852206 Free PMC article. Clinical Trial.
-
Omega-3 fatty acid supplementation combined with acute aerobic exercise does not alter the improved post-exercise insulin response in normoglycemic, inactive and overweight men.Eur J Appl Physiol. 2016 Jun;116(6):1255-65. doi: 10.1007/s00421-016-3387-x. Epub 2016 May 7. Eur J Appl Physiol. 2016. PMID: 27155848 Clinical Trial.
-
Plasma phospholipid EPA and DHA are divergently associated with overall mortality in newly diagnosed diabetic patients: results from a follow-up of the Nord-Trøndelag Health (HUNT) Study, Norway.J Nutr Sci. 2013 Nov 19;2:e35. doi: 10.1017/jns.2013.30. eCollection 2013. J Nutr Sci. 2013. PMID: 25191585 Free PMC article.
-
Inflammatory markers after supplementation with marine n-3 or plant n-6 PUFAs: A randomized double-blind crossover study.J Lipid Res. 2025 Apr;66(4):100770. doi: 10.1016/j.jlr.2025.100770. Epub 2025 Mar 8. J Lipid Res. 2025. PMID: 40058591 Free PMC article. Clinical Trial.
-
The effect of omega-3 and vitamin D co-supplementation on glycemic control and lipid profiles in reproductive-aged women with pre-diabetes and hypovitaminosis D: a randomized controlled trial.Diabetol Metab Syndr. 2020 May 12;12:41. doi: 10.1186/s13098-020-00549-9. eCollection 2020. Diabetol Metab Syndr. 2020. PMID: 32435279 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical